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Scutellaria barbata has a long history of medical use in Traditional Chinese Medicine 
for clearing away heat and toxic material, promoting blood circulation and removing 
blood stasis, and inducing diuresis to reduce edema. Recent pharmacology 
investigations have provided evidence for its anti-cancer, bacteriostasis, anti-virus, anti-
inflammation, anti-oxidation and immunity enhancement properties. The efficacy of 
activating blood circulation and removing blood stasis has unique advantages in the 
treatment of cardiovascular and cerebrovascular diseases. A total of 84 compounds have 
been isolated from S. barbata and characterized mainly as flavonoids, diterpenoids, 
followed by polysaccharide, volatile oil and steroids. Peer-reviewed articles published 
over the last few years were gathered by consulting the databases PubMed, Elsevier, 
Springer and Chinese Herbal Classics. This review mainly focuses on the 
pharmacologically active constituents isolated from S. barbata，which have been 
subjected to in vitro and/or in vivo studies. Although the chemical components, 
pharmacological activities, toxicology, clinical applications and mechanisms of action 
of S. barbata have been investigated, many constituents remain unknown. Further 
investigations are required to investigate the medicinal properties of S. barbata. 
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Scutellaria barbata is a perennial herb belonging to the family Lamiaceae, also 
known as Ban-zhi-lian (barbat sskullcap) in Traditional Chinese Medicine, and mainly 
grows throughout southern China and is a compoment of numerous medicinal formulas 
traditionally used in China and Kore[1]. S. barbata is used for the treatment of inflamed 
throad, severe pain, edema, jaundice, snake bite etc. Due to its ability in clearing away 
heat and toxic material, promoting blood circulation for removing blood stasis, and 
inducing diuresis to reduce edema[2]. Pharmacological studies have provided evidence 
for its anti-tumor, anti-oxidation, anti-bacterial, anti-inflammatory, anti-virus and 
immunonodulatory activities[3]. Clinically, the main indications of S. barbatais are for 
the treatment of sore throat, jaundice, hepatitis and adjuvant treatment of cancer[4]. At 
present, the research and application of the antitumor activity mainly focus on the crude 
extract or the parts extracted from S. barbata[5]. For example, the total flavonoids from 
Scutellarin barbata (TF-SB) can suppress the growth of various tumor cells via several 
specific signaling pathways[6]. S. barbata polysaccharide (SPS) inhibited the 
proliferation of lung adenocarcinoma cells by inhibiting the C-met pathway[7]. 
Scutellarein, a flavonoid monomer found in S. barbata, induced mitochondrial-
mediated intrinsic apoptosis selectively in malignant cells[8]. Its function in activating 
blood circulation and removing blood stasis has important implications for the 
prevention and treatment of cardiovascular and cerebrovascular diseases[9]. 
Experiments have proved that activating blood circulation and removing blood stasis 
has certain effects on anti-thrombosis, improves the function of vascular endothelial 
cells, regulates blood lipids, displays anti-oxidation properties and eliminates free 
radicals[10]. 
Due to the versatile traditional medicinal uses of S. barbata, an increasing number 
of phytochemical studies have been conducted. S. barbata contains a large number of 
alkaloids, flavones, steroids and polysaccharides and other constituents[11]. In recent 
years, a large number of studies have been published on the active constituents of S. 
barbata. Four active components of total flavonoids of S. barbata were analyzed, 
including scutellarin, isoscutellarein-8-O-glucuronide, isoscutellerin and luteolin[12]. 
Some other compounds were also isolated and have been identified as, coumaric acid, 
cinnamic acid, protocatechuic acid, vanillic acid and scutellarin[13-16]. The contents 
of scutellarin and apigenin in S. barbata from 12 different habitats were in the range of 
0.03% - 0.39% and 0.02% - 0.3%, respectively[17]. The present review is focused on 
ethnopharmacological uses, as well as the phytochemical, pharmacological, 
toxicological and clinical uses of S. barbata. The main chemical constituents and 
pharmacological activities of S. barbata were shown in Table 1 and Table 2, 
respectively. 
2. Chemical Composition 
2.1 Flavanoids 
Flavonoids are one of the main physiological components S. barbata[18] and 
scutellarein, scutellarin, carthamidin and isocarthamidin have been identified [19]. The 
above ground part contains wogonin, naringenin, apigenin, hispidulin, eriodictyol, 
luteolin, 7-hydroxy-5, 8-dimethoxyflavone, 4’-hydroxywogonin, 5, 7, 4’-trihydroxy-8-
methoxyflavanone, 5, 7, 4’-trihydroxy-6-methoxyflavanone[20] and Wogonin is 
reported to exhibit anticancer and anti-inflammatory properties[21]. The root contains 
rivularin, 2, 5-dihydroxy-6, 7-trimethoxyflavone, 5,7-dihydroxy-8-methoxyflavone, 5-
hydroxy-7, 8-dimethoryflavone, 5, 2’-dimethoxy-7, 8, 6’-trimethoxyflavone-2’-O-β-D-
glucuronopyranoside, 7-hydroxy-5, 8-dimethoxyflavone-7-O- β -D-glucuronopy-
ranoside, 7-hydroxy-5, 8-dimethoxyflavone-7-O-β-D-glucunopyranoside, 5, 7, 8, 2’-
tetrahydroxyflavone-7-O- β -D-glucuronopyranoside and 5, 2’, 6’-Trihydroxy-7, 8-
dimethoxyflavone-2’-O-β-D-glucuronopyranoside[20]. The average content of total 
flavonoids present in S. barbata is 2.31 ％ , and the leaves contain the highest 
concentration of total flavonoids followed by tender stems, roots, old stems and flowers 
as determined by ultraviolet and visible spectrophotometry [22]. Contemporary 
biomedical experiments have found that flavonoids have significant free radical 
elimination functions both in vivo and in vitro[23]. The content of scutellarin is 7.3％-
10％, luteolin 0.20％-0.60％, apigenin 0.02％-0.30％ and the other compounds have 
also been reported to display potent pharmacological activities[20].  
2.2 Diterpenoids 
Diterpenoids are the other main components of S. barbata, from which the 
scutellones A, B, C, D, E, F, G, H, I and scuterivulactones A, B, C1, C2, D are 
isolated[22]. Qu et al. identified 30 new neo-clerodane diterpenoid compounds isolated 
from S. barbata from Anhui province of China, including Barbatin C, Scutebarbatine 
C, Scutebarbatine D, Scutebarbatine E, Barbatin D, Barbatin E, Scutebarbatine K, 
Scutebarbatine L, Scutebarbatine O, Scutebarbatine B, Scutelinquanine C, 6-
Acetoxybarbatin C, 6-(2, 3-Epoxy-2-isopropyl-n-propoxyl) barbatin C, Barbatin A, 
Barbatin B, Scutebarbatine G, Scutebarbatine F, 6-O-Nicotinoylscutebarbatine G, 6-O-
Nicotinoyl-7-O-acetoxylscutebarbatine G, 6, 7-Di-O-nicotinoylscutebarbatine G, 
Scutehenanine H, Scutelinquanine D, Scutelinquanine A, Scutebarbatine I, 
Scutebarbatine J, Scutebarbatine H, 7-O-Nicotinoylscutebarbatine H, Scutebarbatine M, 
Scutebarbatine N, and Scutelinquanine B[24]. It has been reported recently that the 
extracts of Scutellaria plants, represented by S. barbata, contain antitumor active 
components, most of which are diterpenoids with specific chemical structure[22]. A 
new neoclerodane diterpenoid, barbatin H (1) together with fifteen known analogues 
(2-16) were isolated from S. barbata. All of these compounds displayed cytotoxic 
activities against four human tumor cell lines LoVo (colon cancer), MCF-7 (breast 
cancer), SMMC-7721 (hepatoma cancer), and HCT-116 (colon cancer) cells by MTT 
method in vitro. The series of neoclerodane diterpenoids exhibited varying degrees of 
cytotoxic activities against the growth of the tested tumor cell lines, and most of these 
exhibited selective cytotoxicity against LoVo cell lines. Compound 14 showed 
significant cytotoxic activities against four tested tumor cells with IC50 values of 4.57, 
7.68, 5.31 and 6.23 μM, respectively, indicating potential chemotherapeutic use[25].  
2.3 Polysaccharides 
Polysaccharides are the main class of active constituents required for lymphocyte 
stimulation and antigen-specific immune response induction by traditional medicinal 
herbal plants[26]. The polysaccharides present in S. barbata are polysaccharides (SBP) : 
molecular weight 13000, composed of: Rhamnose, Arabinose, Xylose, Mannose, 
Galactose, Glucose(1.14: 1.5: 0.2: 0.75: 1.0: 2.18); S. barbata polysaccharides SPS4: 
molecular weight 1×104, composed of : Rhamnose, Fucose, Arabinose, Xylose, 
Glucose, Galactose, mannose(0.22: 0.26: 1.0: 0.09: 1.82: 2.09: 0.51)[27]. The SBP 
isolated by Xu et al[28] from dry whole grass and homogeneity polysaccharides SPS4 
isolated by Meng et al. from dry whole grass of S. barbata display immunostimulatory 
and antitumor activity [29]. 
2.4 Volatile oil 
Among the volatile oil of S. barbata, oxygenated monoterpene mainly includes 
menthol, linalool, α-terpineol, thymol; oxygenated sesquiterpene is globulol; 
hydrocarbon sesquiterpene mainly includes β-bourbonene, β-himachalene; other 
compounds with high content are hexahydrofarnesylacetone, 3, 7, 11, 15-tetramethyl-
2-hexadecen-1-ol, 1-octen-3-ol, methyleugenol and other 41 compounds have been 
isolated[18]. Yu et al. have identified 41 components which were extracted by stream 
distillation and analysed by GC-MS analysis: these volatile components display 
antimicrobial activity and have the strongest inhibitory effect on Gram-positive 
bacteria[27]. The Gram-positive bacteria, including methicillin-resistant staphlococcus 
aureus, were more sensitive to the oil than Gram-negative bacteria and yeasts[30]. 
Zhang et al. used simultaneous distillation extraction method to extract the volatile oil 
of the whole grass of S. barbata and found relative higher contents of formylofuran 
(20.53％), thymol (24.10％) and palmitic acid (16.56％), respectively[31]. 
2.5 Other components 
Isolation of E-1-4’-hydroxyphenyl-but-1-en-3-one from S. barbata, organic acids 
contain p-Coumaric acid, protoctechuic acid, ursolic acid, stearic acid, and scutellaric 
acid. S. barbata also contains p-hydroxybenzaldehyde and p-hydroxybenzyl 
acetone[32]. Steroide compounds isolated from S. barbata include campesterol, 
cholesterine, stigmasterol, β-sitosterol, α-sitosterol, soybean steroid-4-alkene-3-ketone, 
soybean steroid-5, 22-diene-3-alcohol, 4, 4-dimethyl cholesteric-6, 22, 24-triene, 
ergostane-4, 6,-22-triene-32-alcohol, soybean steroid-3, 5, 22-triene, soybean steroid-
5, 22-diene-3-alcohol-ethanoic ester, ergostane-4, 6, 22-triene-3β-alcohol, sitosterol 
acetate, phytosterin-β-D glucoside, etc[27]. The content of microelements which are 
essential for human function in the whole grass of S. barbata was determined by 
microwave digestion and flame atomic absorption spectrometry (AAS), and a higher 
content of Fe, Cu, Zn, Mn, Ca, and Mg [33] which has the highest concentration 
followed by Fe and Cu and Zn, Mn, etc[32]. The chemical structures of some major 



































3. Pharmacological activities 
3.1 Anti-cardiovascular diseases 
I/R injury for example myocardial infarction is the major pathological process in 
ischemic heart disease. Scutellarin is a flavone isolated from S. barbata and Xu et al[34] 
examined its therapeutic effect on cardiomyocyte I/R injury in vitro at doses of 25, 50 
and 100 μM, which enhanced JAK2/STAT3-dependent pro-survival signaling and anti-
oxidative response, and thus protected cardiomyocytes from I/R injury-induced 
oxidative stress and apoptosis. Guo et al.[35] has reported the neuroprotective effects 
of scutellarin both in vivo and in vitro. In vivo, intraperitoneal injections of scutellarin 
(20 and 60 mg/kg) diminished the percentage of brain infarct volume and enhanced 
endogenous antioxidant activity. In vitro, pretreatment of scutellarin (25, 50 and 100 
μM) protected neurons against lethal stimuli, decreased the percentage of apoptotic 
cells and inhibited reactive oxygen species (ROS). Scutellarin also decreases infarct 
volume, frequency and distribution of activated microglia and suppresses the 
production of inflammatory mediators in activated microglia in MCAO rats. It appears 
to be more potent in its anti-inflammatory effects and exerts its action via TNF-α 
expression and has proved to be a efficacious therapeutic strategy for the treatment of 
microglia mediated neurodegenerative diseases [36].  
Wogonin, a flavonoid derived from S. barbata, has previously been shown to have 
therapeutic potential for the treatment of atherosclerosis and restenosis. It suppressed 
the proliferation of vascular smooth muscle cell and inhibited the TNF-α induced 
MMP-9 secretion through suppression of the transcriptional activity of MMP-9 gene in 
HASMC[37]. The neuroprotetive effect of wogonin was demonstrated and confirmed 
by using a permanent model of focal brain ischemia in rats. It reduced the permanent 
focal ischemic brain injury induced by pMCAO and improved behavioral deficits in 
rats[38]. 
Naringenin is another flavonoid present in many plants including S. barbata. 
Naringenin treatment protected against mi/r injury by inhibiting oxidative stress via 
activation of cgmp-pkgiα signaling[39]. These findings may provide new mechanistic 
insight into the cardioprotective effects of naringenin, highlighting the opportunity of a 
novel therapeutic strategy for the patients with ischemic heart disease. 
3.2 Anti-tumor activity 
3.2.1 Lung cancer 
Wogonin, has been reported to exhibit anticancer and antiinflammatory properties. 
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins in 
inflammatory conditions[40]. A study investigated the effect of wogonin on phorbol 
12-myristate 13-acetate (PMA)-induced COX-2 expression. The results indicated that 
MEK1/2-AP-1 was very important for PMA-induced COX-2 expression and wogonin 
inhibited PMA-induced AP-1 activation and c-Jun expression, which is a key 
component of AP-1[37]. Scutebarbatine A (SBT-A), one of the major alkaloids from S. 
barbata, has a notable antitumor effect on A549 cancer via mitochondria-mediated 
apoptosis. In vitro, SBT-A can significantly inhibit the proliferation of A549 cell lines 
at concentrations of 20 to 80 μg/mL, up-regulate the expressions of cytochrome c, 
caspase-3 and 9, and down-regulate the levels of Bcl-2 in A549 cells. In vivo, 
intraperitoneal injection of SBT-A (40 mg/kg) to mice resulted in a significant 
suppression of tumor growth [41]. 
Polysaccharides isolated from S. barbata（PSB）at doses of 10, 20, 40 and 80 
µg/ml potently inhibited cell proliferation and human epidermal growth factor receptor 
(HER) 2 phosphorylation in vitro. In vivo, PSB displayed significant antitumor activity 
through reducing microvessel density in a Calu-3 subcutaneous xenograft model at 
doses of 100 mg/kg and 200 mg/kg administered intraperitoneally once daily[42]. The 
treatment with 0.5 mg/ml S. barbata triggered P38/SIRT1-regulated cell apoptosis 
through G2/M phase arrest and ER stress-, intrinsic mitochondrial-, and extrinsic 
FAS/FASL-mediated pathways in CL1-5 tumor cells. In vivo, i.p. injection of S. 
barbata (60 mg/kg) significantly reduced tumor size with decreased proliferation and 
angiogenesis, as well as increased apoptosis and autophagy in CL1-5 tumor bearing 
mice[43].  
3.2.2 Liver cancer 
S. barbata at an oral dose of 6, 3 and 1.5 g/d per kg of body weight when given to 
rats inhibited the proliferation of H22 cells in a time-dependent manner. The extract 
also induced apoptosis of H22 cells via losing their mitochondrial transmembrane 
potential, releasing mitochondrial cytochrome C into cytosol and increasing caspase-3 
activity in a dose-dependent manner[44]. 
Metastasis is the major cause of cancer-related deaths and targeting this process 
has been proposed as a strategy to fight cancer[45]. Dai et al. investigated the anti-
metastatic effect of total flavonoids of S. barbata (TF-SB). The results showed that TF-
SB (20, 40, 60, 80, 100, 120 and 140 μg/mL) significantly inhibited the activity of 
proliferation and invasion and reduced the metastatic capability of MHCC97H cells in 
a dose-dependent manner, probably through decreasing the MMP expression and 
increasing the TIMP expression[11]. S. barbata extract also inhibited the proliferation 
of HepG2 cells in vitro at the doses of 0.05, 0.1, 0.2, 0.3, and 0.5 mg/mL and suppressed 
the tumor growth of hepatoma H22-bearing mice at the doses of 50, 100, and 150 
mg/kg/day by intragastric administration. Meanwhile, it increased NK cells’ 
cytotoxicity in spleen, down-regulated the amount of CD4+CD25+Foxp3+ Treg cells and 
Th17 cells in tumor tissue, and decreased IL-10, TGF-β1, and IL-17A levels whereas 
increased IL-2 and IFN-γ levels in the serum of hepatoma H22-bearing mice[46]. 
3.2.3 Colorectal cancer 
The ethanol extract of S. barbata (EESB) at doses of 0.5, 1.5 and 2.5mg/ml 
significantly inhibited the IL-6-mediated increase in STAT3 phosphorylation and 
transcriptional activity in HT-29 human colon carcinoma cells, resulting in the 
suppression of cell proliferation and the induction of apoptosis[47]. EESB at doses of 
0.125, 0.25, 0.5, 1, 1.5 and 2 mg/ml significantly reduced HCT-8 cell viability, 
attenuated the migration and invasion ability of HCT-8 cells in a dose-dependent 
manner, decreased the expression levels of MMP-1, MMP-2, MMP-3/10, MMP-9, 
MMP-13, phosphoinositide 3-kinase (PI3K)/AKT and transformed growth factor 
(TGF)-β/Smad [48]. 
Angiogenesis, which plays a critical role during tumor development, is tightly 
regulated by the Sonic Hedgehog (SHH) pathway known to malfunction in many types 
of cancer[49]. Inhibition of angiogenesis via modulation of the SHH signaling pathway 
has become very attractive for cancer chemotherapy and it might be one of the 
mechanisms by which S. barbata was effective in the treatment of cancers[50]. The 
intra-gastric administration with 2g/kg of EESB reduces tumor size without increase in 
body weight in CRC mice. EESB treatment suppressed the expression of key mediators 
of the SHH pathway in tumor tissues, which in turn resulted in the inhibition of tumor 
angiogenesis. Furthermore, EESB treatment inhibited the expression of vascular 
endothelial growth factor A (VEGF-A), an important target gene of SHH signaling and 
functioning as one of the strongest stimulators of angiogenesis[51].  
3.2.4 Gastric adenocarcinoma 
S. barbata had a dose-dependent cytotoxic effect on MKN-45 cells. Treatment 
with the ethanol extract of S. barbata inhibited the proliferation and promoted the 
apoptosis of human gastric adenocarcinoma cells by modulating the caspase-, MAPK- 
and ROS-dependent pathway[1]. 
3.2.5 Ovarian cancer 
The extract of S. barbata (0, 100, 200, 400 μg/ml) reduced the viability of ovarian 
cancer A2780 cells and induced apoptosis by down-regulating Bcl-2 protein expression 
and increasing Caspase 3/9 proteins expression. Furthermore, the migration activity of 
A2780 cells was significantly inhibited and the underlying mechanism is probably 
related to the decrease of MMP-2/9[52].  
3.2.6 Leukemia 
The treatment with various concentrations (0.2, 0.5, and 1.0 mg/ml) of S. barbata 
extract (SBE) resulted in apoptosis of HL-60 cells by an increase in sub-G1 phase cells, 
DNA fragmentation and degradation of the inhibitory protein for the caspase-activated 
deoxyribonuclease[53]. The methylene chloride extract of S. barbata (MCSB) inhibited 
the proliferation of human U937 leukemia cells in a dose-dependent manner (IC50=10 
μg/ml), and increased the sub-G1 DNA content. Caspase-9 and caspase-3 were activated 
by MCSB while caspase-8 was intact. Similarly, MCSB effectively cleaved PARP, 
increased the ratio of Bax/Bcl-2 and the release of the cytochrome c from mitochondria, 
causing apoptosis in U937 cells[54]. 
3.2.7 Other tumors 
BZL101, an aqueous extract from the S. barbata plant, inhibited reproductive 
cancer growth in many cell lines by regulating expression levels of key cell cycle 
components that differ with respect to the cancer cell phenotypes, such as early stage 
estrogen sensitive MCF7 cells, early stage androgen sensitive LNCap cells, late stage 
hormone insensitive breast cancer MDA-MB-231 cells and prostate cancer pC3 cells 
[55]. In male TRansgenic adenocarcinoma of mouse prostate mice were given S. 
barbata extract orally at a dose of 8, 16, or 32 mg/kg and the prostate tumor progression 
was delayed as determined by histological assessment[56]. 
S. barbata also inhibited the growth of leiomyomal cells (LM) in a time-dependent 
manner. Pregnant Sprague-Dawley rats were administered drinking water containing 
20g/L or 50g/L of S. barbata extract. The results indicated that the extract reduced the 
expression of Bcl-2 protein in human uterine leiomyoma cells enhanced by 
progesterone[57]. TF-SB (40, 80, 120,160 or 200 µg/ml) inhibited the proliferation, 
migration and invasion of MDA-MB-231 cells in a dose-dependent manner. In vivo, 
TF-SB prevented bone metastasis of breast cancer cells in a dose-dependent manner, 
but did not affect tumor growth or mouse survival. Molecular analysis revealed that TF-
SB controlled the secretion of osteolysis-related factors PTHrP and its downstream 
ranKl/oPG[58]. 
3.3 Antibacterial activity 
S. barbata extract displays antibacterial effects both in vitro and in vivo. The 
bacterial load showed a significant decrease in the lungs of the XDRAB pneumonia 
murine which received the oral S. barbata extract (200 mg/kg) in comparison to the 
control group[59]. In addition, the histopathological examination also revealed better 
resolution of perivascular, peribronchial, and alveolar inflammation in the S. barbata 
extract-treated group. The ability to affect multiple target signaling pathways is a 
potential mechanism of action and might be related to its efficacy of removing heat and 
counteracting toxicity[60]. The essential oil of S. barbata displayed a broad 
antimicrobial spectrum and exerted a stronger bactericidal effect against gram-positive 
bacteria, including methicillin-resistant S. aureus (MRSA). The antimicrobial activity 
of the oil was possibly related to menthol and long chain alcohols such as linalool and 
1-octen-3-ol, menthol has been reported to have significant antimicrobial activity[61]. 
Linalool has been demonstrated to have strong inhibitory effect against 17 bacteria and 
10 fungi. In fact, long chain (C6-C10) alcohols were particularly active against gram-
positive bacteria, and the antimicrobial properties of alcohols are known to increase 
with molecular weight[62]. According to recent studies, community-acquired or 
outpatient MRSA infections are increasing in both children and adults, MRSA is 
responsible for worldwide outbreaks of nosocomial infections. The essential oil of S. 
barbata is a potential source of novel antimicrobial essential oils[60].  
3.4 Antiviral activity 
Neo-clerodane diterpenoids were reported to have significant inhibitory effect on 
EBV lytic replication. Bioassay-guided fractionation was conducted on an EtOAc-
soluble extract of the whole plant of S. barbata, monitored by inhibition of Epstein-
Barr virus (EBV) lytic replication[63]. 
3.5 Anti-inflammatory activity 
Liu et al. reported S. barbata anti-inflammatory activity in RAW 264.7 cells. Both 
ethanol and ethyl acetate extracts at the doses of 50, 100, 200 mg/mL significantly 
inhibit the production of lipopolysaccharide-induced nitric oxide, prostaglandin E2, 
interlukin-6, and interlukin-1β, as well as the expression of phosphor extracellular 
signal-regulated kinase and phosphor-c-Jun N-terminal kinase (p-JNK)[64].  
3.6 Antioxidant activity 
Superoxide radical is a highly toxic species which can be generated by numerous 
biological and photochemical reactions. In addition to directly attacking important 
biological molecules, superoxide radical may also decompose to form singlet oxygen 
and hydroxyl radicals, which may increase local oxidative stress and initiate cellular 
damage or lipid peroxidation and pathological incidents such as arthritis and 
Alzheimer’s disease[65]. Superoxide scavenging activities of polysaccharides from S. 
barbata (SBP) was found to increase with increasing concentrations, and the 
superoxide radical scavenging rate of SBP at 1.0 mg/ml was 67.1％. The IC50 value for 
eliminating superoxide was 0.17 mg/ml, indicating that the polysaccharides had a 
significant superoxide radical scavenging activity[66]. 
3.7 Anti-MDR activity 
Scutellarin, scutellarein and 5,7,4’-trihydroxy-8-methoxy flavanone, flavonoids 
isolated from S. barbata, enhanced the response of CDDP-resistant human OVCAR-3 
cells to CDDP. Cell viability was around 95% and 53% respectively when treated with 
scutellarin, but the viability was dramatically decreased to about 17% when treated with 
the combination of these two compounds, demonstrating a significant synergistic 
effect[67]. The extract of S. barbata (ESB) was able to enhance the sensitivity of MKN-
45 cells to chemotherapeutic agents in vitro. ESB suppressed cell growth more than 
each flavonoid used alone when combined with several chemotherapeutic agents, 
especially cisplatin, etoposide, or doxorubicin, suggesting that ESB increases the 
chemo-sensitivity of MKN-45 cells[1]. 
3.8 Alleviation of memory deficits and neuronal injuries 
Treatment with S. barbata flavonoids at dose of 35-140 mg/kg reduced the 
memory impairment and neuronal injury induced by composited Aβ, including neuron 
loss or pyknosis in hippocampus, typical colliquative necrosis in cerebral cortex, 
mitochondrial swelling and cristae fragmentation and a large number of lipofuscin 
deposits in the cytoplasm[68]. 
3.9 Insecticidal activity 
1-hydroxynaphthalene from S. barbata oil and its derivatives might be effective 
natural agents for the management of house dust and storage mites. Based on the LD50 
values of 1-hydroxynaphthalene derivatives against D. farinae, D. pteronyssinus, and 
T. putrescentiae, the acaricidal activity of 1-hydroxynaphthalene (2.11, 2.37, and 4.50 
µg/cm2) was 4.76, 6.00, respectively. [69]. 
4. Toxicology 
Li et al. reported the toxicity observation of large dose of S. barbata（120g） in 
prescriptions. The results showed that no significant changes before and after treatment 
were observed, indicating the safe use of large quantities[70]. 
5. Clinical application 
5.1 Tumor 
50 cases with advanced non-small cell lung cancer were treated with 
the compound of S. barbata and other Chinese medicines with kidney-tonifying efficay 
and another 50 patients in the control group received NP chemotherapy[71]. The results 
showed that the improvement rate of quality of life after 3 years was 66% in the 
treatment group and 36% in the control group (P<0.01). Although the effective rate of 
18% in the treatment group for short-term treatment was lower than 60% in the control 
group (P<0.01), the myelosuppression rate of 6% was also lower than 48% in the 
control group (P<0.01). A retrospective analysis showed that among 375 patients 
treated with S. barbata, the total effective rate was 58.62% (220 cases) [72]. Xiaoji 
Decoction composed of S. barbata, Curcuma Zedoary, Hedyotis Diffusa, Java Brucea, 
Selfheal, Radix Sophorae Flavescentis, Astragalus Mongholicus and Red Ginseng had 
a sensitizing effect on cisplatin chemotherapy and thermochemotherapy, improving the 
curative effect of low-concentration and low-dose chemotherapeutic drugs[73]. 
Compared with the use of chemotherapy alone, Xiaoji Decoction greatly reduced the 
toxicity and side effects of chemotherapeutic drugs, thus improving the chemotherapy 
tolerance of patients. After 32 ovarian cancer cases were treated with the compound 
Tuyuan Decoction containing S. barbata, the total effective rate was 75％[74]. This 
prescription has many anticancer effects, such as inhibiting tumor angiogenesis, 
inducing apoptosis of cancer cells, killing cancer cells, enhancing immunity. The tumor 
continued to shrink, immunity was enhanced, adverse reactions were small, and no 
granulocytopenia, liver and kidney function damage and other serious reactions were 
noticed. After treatment with S. barbata prescription plus interventional therapy, the 
effective rate of 90.6% for 32 cases with various malignant tumors including liver 
cancer, gastric cancer, and esophageal carcinoma was higher than 74.2% in the control 
group treated with interventional therapy alone (P＜0.005) [75]. 
5.2 Hepatitis 
105 cases with Hepatitis B were treated with Yi-Gan-Fang decoction containing S. 
barbata and 60 cases taking western medicine as control. The results showed the 
effective rate of alleviating main symptoms in the treatment group was higher than that 
in the control group (P < 0.05). The difference in ALT and TBiL levels was significant 
between the two groups (P < 0.05), and the negative change of HBeAg HBV-DNA was 
significantly different between the two groups also (P < 0.05) [76]. 78 hepatitis liver 
fibrosis cases were treated with Ruan-Gan powder containing S. barbata. The results 
showed the clinical symptoms were alleviated and liver function and HA, LN, PCⅢ of 
liver fibrosis parameters recovered in the treatment group. The abnormal index of CⅣ 
was significantly improved in the treatment group compared with the control group (P 
< 0.05) [77]. 
5.3 Gastropathy 
61 patients with precancerous lesions of chronic atrophic gastritis were treated with 
Qilian-Shupi granule[78]. The total effective rate was 80.3% in the treatment group and 
70.0% in the control group (P < 0.05). The clinical symptom score, gastric mirror image, 
pathological curative effect, pathological score and inhibition of H. pylori in the 
treatment group were significantly different from those in the control group (P < 0.01, 
P < 0. 05). After treatment, serum SOD increased and LPO decreased significantly. 
When S. barbata and Hedyotis Diffusa were combined with other Chinese medicines 
to treat 87 cases with chronic gastritis, the cure rate was 89.7% and the effective rate 
was 100%[79]. The total effective rate was 83.3%, when 30 chronic atrophic gastritis 
cases were treated with Yiwei Decoction containing S. barbata[80]. 
5.4 Gynecological diseases 
Guo et al. [81] used antibiotics to control infection, and the Traditional Chinese 
Medicine prescription (Field Pennycress，Scutellaria Barbata, Dandelion, Radix 
Paeoniae Rubrathe, Peach Kernel, etc.) was added to treat 96 cases with chronic pelvic 
inflammatory disease simultaneously. Of 96 cases, 71 were cured, 25 were improved, 
the cure rate being 73.96%. Yiqing Decoction（Codonopsis Pilosula，Astragalus 
Mongholicus，Raw Semen Coicis, Alisma Orientalis, Scutellaria Barbata）was taken 
orally and meanwhile Man-pen NO.1 decoction was applied by enema for 56 cases with 
chronic pelvic inflammatory disease. The total effective rate was 89.3% in the treatment 
group compared to that of 59.3% in the control group (P < 0.01) [82]. 
5.5 Nephropathy 
Yangyin decoction containing S. barbata was applied to treat Henoch-Schonlein 
purpura nephritis[83]. The treatment group of patients received Yangyin Decoction 
(n=30) and the control group of received Glucosidorum Tripterygll Totorum tablets 
(n=30). The total effective rate was significantly higher in the treatment group than that 
in the control group (P < 0.05). The treatment group was superior to the control group 
in controlling the clinical symptoms and improving the indexes of laboratory 
examination (P < 0.05 or P < 0.01). Yiqi-Huoxue-Jiangzhuo prescription was used to 
treated 48 patients with chronic renal failure[84]. The total effective rate in the 
treatment group was 91.67% compared to that of 75.0％in the control group (P < 0.05). 
5.6 Prostatic diseases 
Zhang et al.[85] treated 60 cases of chronic prostatitis with the Decoction 
combined with S. barbata. The results showed that 38 cases were cured, 18 cases 
improved, and 4 cases were unresponsive, the total effective rate being 93.3%. Zhang 
et al.[86] also applied Qilong Decoction containing S. barbata to treat 55 cases of senile 
prostatic hypertrophy. The results showed that 45 cases were cured, 8 cases improved, 
and 2 cases were unresponsive, the total effective rate being 96.36%.  
5.7 Other diseases 
Wang [74] retrospectively analyzed clinical data of 375 patients treated with S. 
barbata. 168 patients with urinary blood were treated with Ban-zhi-lian decoction 
comprised of S. Barbata, Astragalus Bunge, Rhizoma Anemarrhenae, Rhizoma 
Imperatae, Golden Cypress and Eclipta Alba as a basic drug. 62 cases of urinary calculi 
were treated by Huayu-Paishi decoction composed of S. Barbata, Desmodium. S. 
Barbara, Semen Celosiae, and Radix Salviae Miltiorrhizae as main medicine. S. 
barbata eye drops were applied to treat 56 cases of viral keratitis. Total effective rate 
in patients treated with S. barbata were 58.62% (17 cases), 100.00% (81 cases), 96.77% 
(146 cases), 86.90% (60 cases) and 94.64% (53 cases), respectively. 
6. Conclusion 
S. barbata is commonly used in clinic for clearing away heat, detoxification, anti-
cancer, and as an anti-inflammatory agent. The chemical constituents mainly contain 
flavonoids, diterpenoids, alkaloids, steroids, etc. S. barbata can treat cardiovascular and 
cerebrovascular diseases by improving the blood supply of cardio-cerebrovascular 
system via activating the blood vessels of human body and making the blocked blood 
vessels unobstructed. Recent pharmacological studies have shown that S. barbata 
possesses anti-tumor, anti-virus, bacteriostasis and anti-inflammatory effects, 
indicating very high medicinal value. At present, S. barbata capsule and tablets are 
produced in the domestic market for the treatment of the pharyngalgia caused by acute 
pharyngitis. Recent studies focusing on molecular targets of plant derived chemical 
constituents have yielded promising results, but the details of the mechanisms involved 
need to be clarified further. Even though some effective plant derived drugs have been 
developed from S. barbata, there still remains an untapped resource in it. Therefore, 
numerous constituents deserve further investigations in vitro and in vivo due to their 












Table 1. Compounds isolated from Scutellaria barbata 
Classification Chemical component Part of plant Ref. 
1. Flavanoids    
1.1 Flavone Moslosooflavone   Root [87] 
 7-hydroxy-5-methoxy flavonoid   Root [88] 
 7-hydroxy-5, 8-dimethoxyflavone  Aboveground part [20] 
 Chrysin    Whole herb [18] 
 Wogonin Aboveground part [20] 
 5, 7-dihydroxyl-8, 2’-dimethoxy flavone Whole herb [18] 
 Panicolin Whole herb [18] 
 Rivularin Root [20] 
 Anisomelin Whole herb [89] 
 7, 2’-dyhydroxyl-5, 8-dimethoxy flavone Whole herb [18] 
 Baicalein whole herb [90] 
 5, 6, 2’-trihydroxyl-7, 8-dimethoxy flavone Whole herb [18] 
 2’-hydroxychrysin  Whole herb [18] 
 Scutevulin Root [18] 
 Apigenin Aboveground part [20] 
 Hispidulin Aboveground part [20] 
 4’-hydroxywogonin Aboveground part [20] 
 Scutellarein whole grass [91] 
 5, 7,8, 4’-tetrahydroxyl flavone whole grass [18] 
 5, 7, 2’, 3’-tetrahydroxyl flavone whole grass [92] 
 Luteolin Aboveground part [20] 
 5, 7, 8, 2’-tetramethyl flavone whole grass [18] 
 5, 7, 8, 4’-tetramethyl flavone whole grass [18] 
 5, 7, 8, 2’, 6’-pentamethoxyl flavone whole grass [18] 
1.2 Flavonone Naringenin Aboveground part [20] 
 5, 7, 4’-trihydroxy-6-methoxyflavonone Aboveground part [20] 
 5, 7, 4’-trihydroxy-8- methoxyflavonone Aboveground part [20] 
 Carthamidin whole grass [19] 
 Isocarthamidin whole grass [19] 
 Eriodictyol   Aboveground part [20] 
1.3 Flavonoid 
glycoside 
5-hydroxyl-7, 8, 2’-trimethoxy flavones-6’-o-β-d-glucoside whole herb [18] 
 7-hydroxy-5,8-dimethoxyflavone-7-O-β-D-glucuronopyranoside Root [20] 
 5, 2’-dyhydroxyl-7, 8-dimethoxy flavones-6’-o-β-d-glucoside whole grass [18] 
 5, 2’-dyhydroxyl-7, 8, 6’-trimethoxy flavones-2’-o-β-d-glucoside Root [20] 
 5, 2’, 6’-trihydroxy-7, 8-dimethoxyflavone-2’-O-β-D-glucuronopyranoside Root [20] 
 Scutellarin whole herb [19] 
 5, 8, 4’-trihydroxy-7-o-β-d-glucoside whole herb [18] 
 5, 7, 8, 2’-tetrapydroxyflavone-7-O-β-D-glucuronopyranoside Root [20] 
2. Diterpenoids Scutellone A whole herb [93] 
 Scutellone B whole herb [93] 
 Scutellone C whole herb [93] 
 Scutellone D whole herb [93] 
 Scutellone E whole herb [93] 
 Scutellone F whole herb [93] 
 Scutellone G whole herb [93] 
 Scutellone H whole herb [93] 
 Scutellone I whole herb [93] 
 Scuterivalactone A  whole herb [18] 
 Scuterivalactone B whole herb [18] 
 Scuterivalactone C1 whole herb [18] 
 Scuterivalactone D whole herb [18] 
 Scuterivalactone C2 whole herb [18] 
3. Alkaloid Scutebarbatins A whole herb [94] 
 Scutebarbatins b whole herb [95] 
 Scutebarbatins c whole herb [96] 
 Scutebarbatins d whole herb [96] 
 Scutebarbatins e whole herb [96] 
 Scutebarbatins f whole herb [96] 
4. Steroide Campesterol whole herb [97] 
 Cholesterine Root [97] 
 Stigmasterol Root [97] 
 Β-sitosterol Root [97] 
 Gamma-sitosterol whole herb [97] 
 Soybean steroid-4-alkene-3-ketone whole herb [97] 
 Stigmasta-5, 22-dien-3-ol whole herb [97] 
 Cholesta-6, 22, 24-trien, 4, 4-dimethyl- whole herb [97] 
 Ergosta-4, 6,-22-trien-3.alpha-ol whole herb [97] 
 Stigmastan-3, 5, 22-trien whole herb [97] 
 Stigmasta-5, 22-dien-3-ol, acetate whole herb [97] 
 Erogosta-4, 6, 22-trien-3.beta.-ol whole herb [97] 
 Sitosterol acetate whole herb [97] 
 Phtosteryl-β-D- glucoside whole herb [98] 
















 Volatile oil whole herb [31] 
 Scutellaric acid whole herb [99] 
 P-Cournaric acid whole herb [20] 
 Protoctechuic scid whole herb [20] 
 Ursolic acid whole herb [20] 
 Stearic acid  whole herb [97] 
 Microelements whole herb [33] 
 E-1-4’-hydroxyphenyl-but-1-en-3-one whole herb [99] 
 P-hydroxybenzaldehyde Aboveground part [20] 
 P-hydroxybenzylacetone Aboveground part [20] 
Table 2. Summary of Pharmacological activities of S. barbata 
Sort 
Effective part or 
phytochemicals 








Inhibited proliferation Up-regulated the expression of cytochrome c, 
caspase-3 and 9, and down-regulated the levels of 









Calu-3 Inhibited proliferation 
Inhibited human epidermal growth factor receptor 
(HER)2 phosphorylation, downregulated the 








P38/SIRT1-regulated cell apoptosis through G2/M 
phase arrest and ER stress-, intrinsic mitochondrial-, 




Inhibited proliferation and 
angiogenesis 






1.5, 3or6g/d per 
kg 
H22 
Inhibited proliferation and 
induced apoptosis 
ESB-treated cells rapidly lost their mitochondrial 
transmembrane potential, released mitochondrial 








Inhibited proliferation and 
invasion 
Decrease of the MMP expression, and simultaneous 








 Down-regulation  of Treg cells and manipulating 












Inhibited proliferation and 
induced apoptosis 







migration and invasion 
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angiogenesis 











Induced apoptosis and 
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A2780 Induced apoptosis 









Inhibited cell growth and 
induced apoptosis 
 
Downstream of the CDK inhibitory protein-
CDK/cyclin cascade, SBE decreased phosphorylation 







Inhibited proliferation and 
induced apoptosis 
Increased the sub-G1 DNA contents. Caspase-9 and 
caspase-3 were activated while caspase-8 was intact 
by MCSB. Cleaved PARP, increased the ratio of 









MCF7 Inhibited proliferation 
Induced a G1 cell cycle arrest and ablated expression 
of key G1 cell cycle regulators Cyclin D1, CDK2 and 
CDK4, growth factor stimulatory pathways and 

















migration and invasion 

















Decreased bacterial load in 
the lungs 
Affected multiple target signaling pathways and their 


















toward RAW 264.7 cells 
Inhibited the production of lipopolysaccharide-
induced nitric oxide, prostaglandin E2, interlukin-6, 
and interlukin-1β, inhibited the expressions of 
phosphor extracellular signal-regulated kinase and 




















Enhanced sensitization to 
cisplatin 
Correlated with the positions of hydroxyl group and 












Enhanced JAK2/STAT3-dependent pro-survival 
signaling and anti-oxidative response, and thus 
protected cardiomyocytes from I/R injury-induced 
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